These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. Mannucci PM; Cugno M Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489 [TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Shenkman B; Einav Y Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304 [TBL] [Abstract][Full Text] [Related]
5. HUS and TTP: traversing the disease and the age spectrum. Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684 [TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki Y; Fujita T Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023. Matsumoto M; Miyakawa Y; Kokame K; Ueda Y; Wada H; Higasa S; Yagi H; Ogawa Y; Sakai K; Miyata T; Morishita E; Fujimura Y; Int J Hematol; 2023 Nov; 118(5):529-546. PubMed ID: 37689812 [TBL] [Abstract][Full Text] [Related]
8. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura]. Matsumoto M Rinsho Ketsueki; 2021; 62(5):480-485. PubMed ID: 34248125 [TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathies: from animal models to human disease and cure. Caprioli J; Remuzzi G; Noris M Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of TMA based on Japanese clinical guides]. Wada H; Hasegawa K; Watanabe M Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284 [TBL] [Abstract][Full Text] [Related]
13. [Treatment strategy for patients with thrombotic thrombocytopenic purpura]. Yagi H Rinsho Ketsueki; 2021; 62(8):1222-1228. PubMed ID: 34497210 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE; Moake JL; Miyata T; George JN Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695 [TBL] [Abstract][Full Text] [Related]
18. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Fujimura Y; Matsumoto M Intern Med; 2010; 49(1):7-15. PubMed ID: 20045995 [TBL] [Abstract][Full Text] [Related]
19. [Frontline clinical practice for thrombotic thrombocytopenic purpura]. Miyakawa Y Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of thrombotic thrombocytopenic purpura]. Kubo M; Matsumoto M Rinsho Ketsueki; 2020; 61(5):529-535. PubMed ID: 32507820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]